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To assess the premise that genetically determined di¡er-
ences in susceptibility to UV-induced immunosuppres-
sion are re£ected in UV carcinogenesis, we investigated
UV skin cancer induction in two strains of reciprocal F1
hybrid mice CB6F1 males with high susceptibility to
UV immunosuppression and a BALB/c X-chromosome
and B6CF1 males with low susceptibility to UV immu-
nosuppression and a C57BL/6 X-chromosome. Four ex-
perimental groups comprising both strains treated three
times weekly with two UVregimens (daily doses incre-
mented from 2.25 to 6 or 4.5 to 12 kJ per m2) were
monitored for skin tumor development. Survival with-
out a skin tumor di¡ered over the four groups (po
0.0001) and di¡ered according to UV regimen within
each strain (po0.0005). Di¡erences between strains were
signi¢cant for the higher dose (p¼ 0.03) but not for the
lower dose (p¼ 0.19) of UV, suggesting a dose^strain
interaction. Comparing the higher UV dose regimen
to the lower UV dose regimen within a strain at three
reference points, tumor-free survival was reduced sig-
ni¢cantly more (po0.05) in the CB6F1 mice than in
the B6CF1 mice. Histologic assessment of all tumors
revealed ¢brosarcomas, squamous carcinomas, and
mixed tumors. Immunohistochemistry of the mixed
tumors for vimentin, keratin, and E-cadherin con-
¢rmed the presence of squamous and ¢brosarcomatous
elements. The enhanced susceptibility to UV carcino-
genesis of CB6F1 males treated with the higher UV
pro-tocol was attributable to a signi¢cantly enhanced
proportion (po0.005) of mixed tumors. Analysis of the
data by comparing the proportion of animals tumor
free at three reference time points con¢rmed a dose^
strain interaction only in the development of mixed tu-
mors, putatively the malignantly advanced carcinomas
(po0.03). A dose^strain interaction was also observed
for systemic UV immunosuppression of contact hyper-
sensitivity (po0.025). These ¢ndings support the con-
cept that genetic di¡erences in susceptibility to UV-
induced immunosuppression may be a risk factor for
skin cancer. Key words: skin cancer/risk factor/ultraviolet ra-
diation/immunosuppression. J Invest Dermatol 121:1175 ^1181,
2003
A
relationship between sunlight exposure and skin
cancer is well established, although the quantitative
parameters of this relationship are not well under-
stood (International Agency for Research on Can-
cer, 1992; Armstrong and Kricker, 1995). The
incidence of all types of skin cancer is increasing worldwide
(Howe et al, 2001; SEERdata, http://seer.cancer.gov; International
Agency for Research on Cancer, 1992). This question is of further
urgency because of the global depletions in the earth’s protective
stratospheric ozone layer which have already been observed to in-
crease ultraviolet (UV) B (290^320 nm) levels at some locations
and are predicted to do so globally (De Fabo, 1992; UNEP
Special Issue, 2003). Even if the Montreal Protocol amendments
in limiting chloro£uorocarbon production are strictly adhered to,
signi¢cant increases in incidence of skin cancers are predicted
worldwide (Slaper et al, 1996). It is therefore critical to identify
risk factors for sunlight-induced skin cancers.
UVB initiates a selective immunosuppression that has been de-
scribed in humans (Hersey et al, 1983; Kelly et al, 2000) as well as
in experimental animals (Fisher and Kripke, 1977; De Fabo and
Kripke, 1979, 1980) (reviewed in Norval, 2002). There is consider-
able evidence from experimental systems that this form of immu-
nosuppression is a critical step in UV carcinogenesis, preventing
immunologic destruction of highly antigenic UV-induced skin
cancers (Fisher and Kripke, 1977, 1982; De Fabo and Kripke, 1979,
1980) (reviewed in Nishigori et al, 1996). We (Noonan and
Ho¡man, 1994a, b) and others (Streilein and Bergstresser, 1988)
have described genetic di¡erences in susceptibility to UV
immunosuppression in inbred mice. We have derived a model
for the genetics of susceptibility to UV immunosuppression in
inbred mice controlled by interacting autosomal and X-linked
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loci (Noonan and Ho¡man, 1994a) and have recently described
autosomal quantitative trait loci for this trait (Clemens et al, 2000).
Reciprocal F1-hybrid males derived from parental BALB/c and
C57BL/6 mice show a di¡erence in susceptibility to UV immu-
nosuppression.The male CB6F1 hybrids, which carry the BALB/c
X-chromosome have signi¢cantly (twofold) greater susceptibility
to UV suppression than the male B6CF1 hybrids (mice derived
from C57BL/6 female and BALB/c male parents), which carry
the C57BL/6 X-chromosome (Noonan and Ho¡man, 1994a). This
appeared to be an X-linked e¡ect rather than other parent of ori-
gin e¡ects because (1) female F1 hybrids from the same reciprocal
matings and that carried both a BALB/c X-chromosome and a
C57BL/6 X-chromosome showed identical susceptibility to UV-
induced immunosuppression and (2) female F1 hybrids had
susceptibility intermediate between the two male phenotypes,
consistent with random X-chromosome inactivation. (3) Further,
o¡spring with the X-chromosome ¢xed as the BALB/c allele, de-
rived from the mating of CB6F1males (which carry the C57BL/6
Y-chromosome) and BALB/c females, showed the same segrega-
tion of phenotype for susceptibility to UV suppression regardless
of sex, eliminating the possibility of a Y-linked e¡ect (Noonan
and Ho¡man, 1994a) and indicating the action of additional auto-
somal loci.
To test the premise that genetically determined increased sus-
ceptibility to UV immunosuppression is associated with en-
hanced susceptibility to skin cancer, we have investigated UV
carcinogenesis in mice with X-linked di¡erences in susceptibility
to UV immunosuppression. Two UV protocols for carcinogen-
esis, which di¡ered by a doubling of the daily UV dose, were
used with male CB6F1 hybrid and B6CF1 hybrid mice, which dif-
fered approximately twofold in susceptibility to UV immuno-
suppression.
MATERIALS AND METHODS
Mice CB6F1 hybrid mice were bred in our colony from parental BALB/
cAnNCr females and C57BL/6NCr males from Frederick Cancer Research
and Development Center; B6CF1 hybrids were similarly derived from
parental C57BL/6NCr females and BALB/cAnNCr males. All animals
had black-agouti hair pigmentation. Animals were maintained on mouse
chow (Laboratory Rodent Diet 5001, Purina Mills Inc., Richmond, IN)
and were kept under a strict 12-h light/dark cycle. All animal experiments
were carried out according to NIH ethical guidelines.
UV irradiation for production of skin tumors Starting at 8 weeks of
age, animals were shaved on the dorsum three times weekly and UV
irradiated in separate compartments of a modi¢ed mouse cage (Noonan
and Ho¡man, 1994b) with a bank of six FS40 sunlamps (60% UVB 290^
320 nm; 40% UVA, 320^400 nm; and o1% UVC, 250^290 nm). Two
incrementally graded UV protocols were used. A lower UV protocol
delivered three times weekly a UV dose of 2.25 kJ per m2 (7.5 min) for 12
treatments (week 1 to week 4), 4.05 kJ per m2 (13.5 min) for 24 treatments
(week 5 to week 12), 5.1 kJ per m2 (17 min) for 12 treatments (week 13 to
week 16), and 6 kJ per m2 (20 min) (week 17 to the end of the experiment).
A higher UVprotocol delivered twice the daily dose of the lower protocol.
The UV dose used did not result in grossly visible acute skin damage,
although erythema was observed with the higher UV protocol with both
strains. Control animals were shaved only.
Tumors Animals were monitored weekly for tumor appearance and
euthanized before any tumor was 1 cm in any dimension. Time to tumor
appearance was calculated as time of the ¢rst observation in which a
palpable lump was observed (41 mm) that progressed to a histologically
identi¢ed tumor. For animals that died tumor free, day of death was noted.
Tumor histology Tumor type was determined by examination of coded
specimens of hematoxylin and eosin-stained sections of formalin-¢xed,
para⁄n-embedded tissue. Tumors showing mixed pathology containing
both squamous and ¢brosarcoma elements were stained for vimentin,
keratin, and E-cadherin. After deceration, antigen retrieval was performed
using the a target retrieval solution as suggested by the manufacturer
(Dako, Carpinteria, CA). Staining was performed using a Dako Auto-
stainer and the Dako Envision kit designed for rabbit antibodies as
directed by the manufacturer. Brie£y, endogenous peroxidase activity was
blocked for 5 min, protein block (Dako) was applied for 10 min, slides
were incubated with primary antibody for 30 min and with the Envision
secondary reagent for 30 min, diaminobenzidine was used for color
development, and then sections were counterstained with hematoxylin,
dehydrated, and mounted. Primary antibodies were rabbit antimouse
keratin 14 (Covance) at a dilution of 1:10,000 and rabbit antivimentin
(BioMeda) at a dilution of 1: 500 or 1: 750. For negative controls for
rabbit antibodies, primary antibodies were replaced with normal rabbit
serum (Dako) or an irrelevant antibody (antihuman secretory component,
Dako) used at equivalent protein or immunoglobulin concentrations,
respectively. The negative control for the mouse monoclonal anti-E-
cadherin antibody consisted of the appropriate immunoglobulin isotype
(IgG2a, Dako) employed at the same concentration and in exactly the
same fashion as the primary antibody.
Immunostaining for E-cadherin was performed using a combination of
the ARK and CSA staining kits provided by Dako according to the
instructions of the manufacturer. The primary antibody was a mouse
monoclonal anti-E-cadherin antibody (BD Biosciences, Franklin Lakes,
NJ) that was biotinylated using the ARK kit as recommended. Slides
were decerated, and antigen retrieval was performed using the TRS
solution (Dako) as recommended by the manufacturer. Staining with
components of the CSA kit was performed as recommended, except that
a biotin blocking step (Dako) was added, and the bu¡er used was a high-
salt version (0.05 M Tris, pH 7.6, 0.3 M NaCl, 0.05% Tween 20) of the Tris
bu¡er usually employed.
UV dose response for suppression of contact hypersensitivity To
investigate dose-dependent di¡erences in susceptibility to UV-induced im-
munosuppression, mice were UV irradiated using the UV source described
above and systemic suppression of contact hypersensitivity to trinitro-
chlorobenzene, determined as described previously (Noonan and Ho¡man,
1994b). Brie£y, mice were shaved on the dorsum, the ears were covered
with black electrical tape, and the mice were UV irradiated in separate
compartments of a modi¢ed mouse cage with the UV source described
above. Three days later, 100 mL of a 1% solution of trinitrochlorobenzene
in acetone was applied to the shaved abdomen. An additional 4 days later,
mice were anesthetized with halothane, and ear thickness was measured
with an engineer’s micrometer (No. 7309, Mitutoyo, Aurora, UL). Five
microliters of a 1% solution of trinitrochlorobenzene was applied to each
surface of each ear, and ear thickness was measured again 24 h later. All ear
measurements were performed in a blinded fashion. Each experiment
included age- and sex-matched mice as negative controls (no UV treatment,
no sensitization to trinitrochlorobenzene) and as positive controls (sensitized
to trinitro-chlorobenzene but no UV treatment). The percentage of sup-
pression was calculated as
% suppression
¼100

1
ear swelling of test animals ear swelling of negative control
ear swelling of positive control ear swelling of negative control
 
:
Because the site of sensitization (unshaved abdominal skin) and the site of
challenge (ear) were protected from UV irradiation, we determined the
systemic suppression by UV.
Statistical analyses Contingency table methods including chi-square
tests were used to analyze associations between strain or treatment and
counts of tumor type. Standard actuarial methods (Miller, 1981) were used
to estimate tumor-free survival functions, the proportion surviving
without tumor in each study group. In particular, Kaplan^Meier product
limit estimates and Greenwood’s formula for the standard error were
adjusted for right censorship owing to early death or euthanization. If the
event was a type of skin tumor, animals were considered at risk and
uncensored until the ¢rst occurrence of the tumor or the death of the
animal even if other tumors occurred. Note that because skin tumors are
visible and their development was carefully monitored, the potential biases
associated with occult tumors were not present (Gart et al, 1986). The
proportional hazards model of Cox was not used because hazard ratios
changed with time for each of the study tumor types.
Survival function estimates were graphed and then compared formally
using two rank tests, each generalized to censored data, the Wilcoxon
statistic (Breslow, 1970) and the log rank test (Mantel, 1966; Cox, 1972).
Tables of survival estimates for selected time points are considered. The
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points were selected based on the proportion of test animals at risk
overall, and in study groups. Relative di¡erences in survival without
tumor were compared using z-tests based on logarithmically transformed
survival estimates. The standard error (SE) of a logarithm was ob-
tained using an application of the delta method (Rao, 1965), i.e.,
SE{ln[S(t)]}¼ SE[S(t)]/S(t), where S(t) is the estimated survival at time t.
Di¡erences between dose responses for UV suppression of contact
hypersensitivity were determined by analysis of variance of deviations
from regression as described previously (Noonan and Ho¡man, 1994b)
RESULTS
Tumor development A summary of tumors derived using the
two UV regimens is given in Table I. The majority (495%) of
tumors appeared on the back, the remainder on the ears or the
eyelid. The mean number of tumors per mouse was 1.5 for all
groups. Control, unirradiated animals (7 males and 20 females)
were shaved three times weekly for 365 days, and no tumors
were observed. Tumors that arose included typical squamous cell
carcinomas, ¢brosarcomas, and tumors with mixed squamous
epithelial and sarcomatous elements. For the higher UV
protocol, tumor types were signi¢cantly di¡erent between male
hybrids, CB6F1 mice developing signi¢cantly more mixed
tumors, containing both squamous carcinoma and ¢brosarcoma
elements, than did B6CF1 mice (Table I, chi-square po0.005).
Kaplan^Meier survival analysis Because observed tumor rates
may be seriously a¡ected by di¡erential survival we consider, in
Fig 1, the Kaplan-Meier estimates of tumor-free survival curves
for the four groups of male mice, each hybrid treated with
either the lower or the higher UV protocol. The observation of
any skin tumor was taken as an event and the tumor-free
survival curve was estimated for each experimental group. A
family of approximately parallel curves was obtained. Time to
tumor-free survival increased stepwise, from animals with high
susceptibility to UV immunosuppression (CB6F1) treated with
the higher UV protocol (¢rst curve on the left, Fig 1) to animals
with low susceptibility to UV immunosuppression (B6CF1)
treated with the lower UV protocol (last curve on the right, Fig 1).
Survival without a skin tumor di¡ered over the four groups (log-
rank test, w2¼ 40.6, d.f.¼3, po0.0001). Survival without skin
tumor di¡ered by treatment with UV dose within each strain
(po0.0005 for B6CF1 and for CB6F1). Survival also di¡ered
between strains. For animals given the low dose of UV the
di¡erence was not signi¢cant (p¼ 0.19), but for animals given
the high dose of UV, the CB6F1 group di¡ered signi¢cantly
from the B6CF1 group (p¼ 0.03), which suggests a dose^strain
interaction.
Time to tumor occurrence by tumor type Survival analysis
of time to tumor development strati¢ed by tumor type was
complicated by the excess of mixed tumors, i.e., tumors containing
both ¢brosarcoma and squamous carcinoma elements, in CB6F1
male mice given a high UV dose. Mixed tumors appeared at a
much greater rate in CB6F1 male mice treated with the higher
UV protocol than in the other groups (Fig 2), and the pro-
portion of mixed tumors in this group was signi¢cantly greater
than in the other three groups (Table I, w2, po0.005). Note the
absence of a dose response for mixed tumor development in
B6CF1mice (Fig 2). In contrast, di¡erences between rates of appear-
ances of typical ¢brosarcomas and squamous carcinomas were
not as marked between the experimental groups (not shown).
Table I. UV-induced tumor development in CB6F1 and B6CF1 hybrid male mice
Tumor type (number)b
Strain Sex UVdosea No. of mice
No. of tumor
bearers
Fibrosarcoma Squamous cell
carcinoma
Mixed Other
CB6F1 M High 50 43 23 18 23
c 2
B6CF1 M High 49 41 33 21 6 2
CB6F1 M Low 55 38 25 20 8 3
B6CF1 M Low 40 30 12 22 8 2
aFor details of UV regimens see Materials and Methods.
bFor details of tumor classi¢cation, see Materials and Methods; the mean number of total tumors/tumor bearer was 1.5 for all experimental groups.
cProportion of mixed tumors was signi¢cantly greater in this treatment group than in any other group (chi-square, po0.005).
Figure1. Tumor-free survival (Kaplan^Meier estimates) in F1 hy-
brid mice. Closed symbols, CB6F1 mice; open symbols, B6CF1 mice. Circles,
data for animals treated with the high UV dose triangles, animals treated
with the low UV dose. For details of UV regimens, see Materials and
Methods.
Figure 2. Tumor-free survival for mixed tumors (Kaplan^Meier
estimates) in F1 hybrid mice. Symbols as for Fig 1.
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To present the time to tumor occurrence results by tumor type,
three reference time points were chosen as follows: The latest day
with at least 75% of the animals alive in each of the four groups
was day 271. Day 296 was the latest with at least 50% alive, and
310 d was the latest with at least 25% alive. Days 271, 296, and
310 were thus used as reference time points for further statistical
analysis.
Time to tumor occurrence by strain In Table II are shown
the percentages of animals tumor-free at the three reference time
points with both UV regimens for each strain of mouse
according to tumor type. Signi¢cant di¡erences were observed
between strains only with the high UV dose regimen (right-hand
columns, Table II). As seen in the survival curves in Fig 1, the
proportion of animals tumor free in the CB6F1 strain was
signi¢cantly lower than in the B6CF1 strain at all three reference
time points when all tumors were considered, regardless of tumor
type (Table II, any tumor). In contrast, there were no signi¢cant
di¡erences when ¢brosarcomas only were considered (Table II,
¢brosarcoma) and signi¢cant di¡erences at only two of the
three reference time points for squamous carcinomas (Table II,
squamous). In contrast, when mixed tumors were considered,
highly signi¢cant di¡erences between the two strains were
observed at all three reference points (Table II, mixed). Thus,
the observed di¡erences between CB6F1 and B6CF1 with the
high UV regimen are driven largely by the di¡erence for mixed
tumors.
Dose^strain interaction The observation that the di¡erences in
tumor-free survival between strains were observed only with the
high UV regimen suggested that a dose^strain interaction was
occurring. To compare the e¡ects of the two UV regimens
between strains, the ratios of the proportions of animals tumor
free at each reference time point were derived from the data in
Table II for each strain. The ratios were then compared between
strains using the percentage of decrease in tumor-free survival for
high UV versus low UV. Di¡erences were signi¢cant for tumors
grouped regardless of tumor type (Table III, any tumor), not
signi¢cant for ¢brosarcomas or squamous carcinomas but were
highly signi¢cant for mixed tumors. Thus a signi¢cant dose^
strain interaction was found in the development of mixed
tumors. The decrease in survival free of a mixed tumor associated
with increasing UV dose regimen was much greater in CB6F1
than in B6CF1 mice.
Immunohistochemical visualization of mixed tumors: 13
tumors of the 23 classi¢ed as mixed tumors in the group of
CB6F1 males irradiated with the high-UV regimen were
Table II. Strain di¡erences in UVcarcinogenesis: Comparison between strains of tumor-free survival (%) by tumor type
within each UV regimen
% tumor free (SE)
Low UV High UV
Tumor type Day CB6F1 B6CF1 p value
a CB6F1 B6CF1 p value
a
Any 271 86 (5) 87 (5) 0.89 53 (7) 75 (5) 0.02
296 63 (7) 71 (7) 0.42 22 (6) 58 (7) 0.00
310 54 (7) 61 (8) 0.51 12 (5) 36 (7) 0.02
Fibrosarcoma 271 94 (3) 92 (4) 0.69 93 (4) 85 (3) 0.22
296 87 (5) 84 (6) 0.70 73 (8) 73 (5) 1.00
310 87 (5) 78 (7) 0.31 64 (9) 70 (5) 0.60
Squamous 271 94 (3) 97 (3) 0.48 77 (6) 94 (3) 0.02
296 81 (6) 89 (5) 0.31 55 (8) 84 (6) 0.01
310 69 (7) 86 (6) 0.07 45 (9) 53 (7) 0.53
Mixed 271 96 (3) 97 (3) 0.81 76 (6) 95 (3) 0.01
296 92 (4) 92 (4) 1.00 60 (8) 93 (4) 0.00
310 87 (5) 86 (6) 0.90 51 (9) 89 (5) 0.00
ap values by z-test after logarithmic transformation.
Table III. Dose^strain interaction: Decrease (%) in tumor free survival associated with change from low-UV regimen to
high-UV regimen for each tumor type and strain
% decrease in tumor free survival for high UV vs. low UV regimen
Tumor type Day B6CF1 CB6F1 p value
a
Any 271 13.8 38.4 0.055
296 18.3 65.1 0.011
310 41.0 77.8 0.049
Fibrosarcoma 271 7.6 1.1 0.450
296 13.1 16.1 0.838
310 10.3 26.4 0.327
Squamous 271 3.1 18.1 0.078
296 5.6 32.1 0.078
310 38.4 34.8 0.845
Mixed 271 2.1 20.8 0.026
296 (1.1)b 34.8 0.004
310 (3.5)b 41.4 0.006
ap values by z-test after logarithmic transformation.
bPercentage increase.
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investigated for keratin, vimentin, and E-cadherin protein
expression by immunohistochemistry (Fig 3). The overlying
epithelium was positive for keratin as expected but in the
tumors, areas of vimentin-positive and keratin-positive cells
were intermixed with regions of transition from keratin to
vimentin staining. Vizualization of E-cadherin in the same
specimens also demonstrated areas highly positive for E-
cadherin adjacent to weakly positive or negative areas. These
¢ndings raise the notion that these tumors were undergoing
epithelial mesenchymal transformation from squamous carci-
nomas to mesenchymal tumors. In all samples the overlying
epithelium was positive and spindle cells were negative for E-
cadherin.
UV dose^strain interaction in susceptibility to UV-immuno-
suppression To investigate the possibility that a dose^strain
interaction occurred in susceptibility to UV-induced immuno-
suppression, UV dose responses for suppression of contact hy-
persensitivity were carried out in CB6F1 and B6CF1 male mice.
(Fig 4). As shown previously using a single standard UV dose
(Noonan and Ho¡man, 1994a), CB6F1 male mice were signi-
¢cantly more sensitive to UV-induced immuno-suppression
than were B6CF1 male mice (po0.025). The UV dose for 50%
suppression in CB6F1 male mice was 2.4 kJ per m
2 and for
B6CF1 male mice was 4.3 kJ per m
2. The slopes of the UV dose
responses di¡ered signi¢cantly and were 138726 (units of
percentage suppression/log10 UV dose) for CB6F1 male mice and
79717 for B6CF1male mice (po0.025). Thus, a signi¢cant dose^
strain interaction was observed for UV immunosuppression,
consistent with the dose^strain interaction observed above
(Table III) in UV carcinogenesis for these strains.
DISCUSSION
In this study, we have addressed the role of UV-induced immu-
nosuppression in UV carcinogenesis. Using information derived
from our previous characterization of genetic control of suscept-
ibility to UV-induced immunosuppression (Noonan and Ho¡-
man, 1994a), we identi¢ed two strains of reciprocal F1-hybrid
male mice which di¡ered approximately twofold in X-chromo-
some-controlled susceptibility to the immunosuppressive e¡ects
of UV. Each strain of mouse was treated with two regimens of
chronic UV, which di¡ered twofold in dose, and then followed
for tumor formation.We found, as predicted, that, in either strain
of mouse, tumors developed signi¢cantly faster in mice treated
with the higher rather than with the lower UV dose regimen.
The e¡ect of strain di¡erences, however, was more complex. At
the higher UV dose, di¡erences between strains were large and
signi¢cant, with CB6F1 mice, which had higher susceptibility to
UV-induced immunosuppression, developing tumors more rapi-
dly than B6CF1 mice, with lower susceptibility. At the low UV
dose regimen di¡erences between strains in tumor outgrowth
were small and not signi¢cant. Multiplicity (mean tumors/
animal) was similar at a mean of 1.5 tumors per mouse for all four
experimental groups.
Three tumor types were identi¢ed by histologic and immuno-
histochemical analyses. These were ¢brosarcomas, which showed
Figure 3. Immunohistochemistry of a
UVR-induced murine tumor. Immu-
nostaining for keratin 14 (A) and vi-
mentin (B) in the same tumor. Arrows in
(B) show cells with an epithelial appearance
that stain faintly for vimentin. An hematox-
ylin and eosin-stained section of the tumor
(C) illustrates the microscopic appearance of
the area shown in A, B. In (D) staining for
E-cadherin in the tumor illustrated in A^C
is shown. The larger arrow indicates cells with
epithelial morphology that express abundant
E-cadherin on cell surfaces; the smaller arrow
points to more spindle-shaped cells that re-
tain only modest E-cadherin expression.
Most tumor cells are E-cadherin-negative.
Insets in A, B, D, control staining with iso-
type-matched irrelevant antibody. A^C, bar,
60 mm; D, bar, 20 mm.
Figure 4. UV dose responses for suppression of contact hypersensi-
tivity in F1 hybrid males. Means7SEM are given for data points (N is
between 3 and 9 animals at each point at each dose). Lines are calculated
regression lines derived from all the data points for each strain. Both the
dose responses show signi¢cant slope (po0.001) and the slopes are signi¢-
cantly di¡erent from one another (po0.025). See text and Materials and
Methods for experimental details. UV exposure times ranged from 4 min
(1200 J per m2; log10 UV¼ 3.08) to 30 min (9000 J per m
2; log10 UV¼ 3.95).
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positive staining for vimentin; squamous cell carcinomas, positive
for keratin and E-cadherin; and mixed tumors, which contained
intermingled elements of both ¢brosarcoma and squamous cell
carcinoma. Further analysis of the carcinogenesis data strati¢ed
by tumor type indicated that there was a signi¢cant excess of
mixed tumors in CB6F1 mice that had high susceptibility to UV
immunosuppression at the higher UV dose. These tumors re-
presented 35% (23 of 66) tumors in this group, in contrast to
the other three groups in which 10%^18% of tumors fell
into this category. This di¡erence was statistically signi¢cant
(Table I). This excess appeared to largely explain the more rapid
appearance of tumors in this group and was visually observed
in Kaplan^Meier survival plots (Fig 2). At three selected time
points, comparing the high-dose regimen to the low-dose regi-
men within a strain at three reference points, tumor-free survival
was reduced signi¢cantly more (po0.05) in the CB6F1 mice than
in the B6CF1 mice; i.e., there is an important stain-UV dose^
strain interaction. This analysis indicated that increasing the UV
dose regimen reduced the time to appearance of mixed tumors in
CB6F1 mice more than in B6CF1 mice and that this interaction
was signi¢cant only for mixed tumors (Table III), con¢rming
the central role of mixed tumors in the enhanced susceptibility
of this group to skin cancer induction.
The mixed tumors may have resulted from separate carcino-
genic events occurring in the epidermis and the dermis. On ¢rst
consideration, if there was an enhanced tendency to multiplicity
(increased number of tumors/mouse) in mice with high suscept-
ibility to UV immunosuppression, it might be expected that the
number of tumors per mouse should be increased, not just at the
site of mixed tumors, but at other locations as well. This was not
observed since the mean tumor multiplicity was 1.5 tumors per
animal for each of the four experimental groups. It is possible,
however, that the microenvironment surrounding the growth of
a ¢rst tumor may promote the progression of a second initiated
cell at the same location resulting in the development of a mixed
tumor. Another possibility is that the mixed tumors result in fact
from a single carcinogenic event and that the transition from
squamous cell to spindle cell phenotype represents a form of
epithelial-mesenchymal transformation, a process by which clo-
sely associated and immobile epithelial cells expressing cytokera-
tin are transformed into dissociated and motile ¢broblast-like
cells that express vimentin (Birchmeier and Birchmeier, 1995).
The visualization of keratin, vimentin, and E-cadherin in our
studies (Fig 3) shows areas consistent with transition from
epithelial to mesenchymal phenotype. The induction of spindle
cell carcinomas in the skin of mice by chemical carcinogens is
well documented (Portella et al, 1994). Spindle cell carcinomas
are believed to represent a late stage of squamous cell carcinoma
progression. The spindle cells comprising advanced chemically
induced tumors have few desmosomes, few of the cells are kera-
tin-positive, and de novo expression of vimentin in tumor cells has
been reported (Can¢eld et al, 1988; Phelps et al, 1989; Makinen and
Stenback, 1998). Similar changes have been reported in UVR-
induced tumors of the mouse (Morison et al, 1986). It has been
demonstrated that transforming growth factor-b can induce
rever-sible squamous to ¢broblast-like morphologic conversion in
murine SCC cells, and this conversion is associated with decreased
E-cadherin expression and with enhanced invasiveness in vivo
(Portella et al, 1998). Epithelial^mesenchymal transformation in
tumors from this study is currently under further investigation.
The disparity between the ¢ndings with the two UV regimens
prompted us to investigate the possibility of a dose^strain inter-
action. Examination of data at three selected time points (Table
III) indicated a concentration^strain interaction when all tumors
were considered and, when strati¢ed by tumor type, revealed a
highly signi¢cant dose^strain interaction for the development of
mixed tumors, further emphasizing the importance of these tu-
mors. Because our aim was to investigate the role of UV immu-
nosuppression, we next investigated the possibility of a dose^
strain interaction in UV immunosuppression. To estimate UV
immunosuppression, we used the method of quantitating the sys-
temic decrease in a contact hypersensitivity response as a function
of UV dose that we have previously used extensively to identify
genetic loci controlling susceptibility to UV immunosuppression
(Noonan and Ho¡man, 1994a, b; Clemens et al, 2000). We
demonstrated a signi¢cant di¡erence in the slopes of UV dose
responses for immunosuppression between CB6F1 and B6CF1
males, indicating a signi¢cant dose^strain interaction in suscept-
ibility to UV immunosuppression. From a comparison of the
slopes of the dose responses, UV immunosuppression increased
as a function of log10 UVdose 1.75 times faster in CB6F1 suscep-
tible mice than in B6CF1mice. Thus, the higher the UVdose, the
greater the disparity between strains in susceptibility to UV im-
munosuppression. This UV dose^strain interaction is consistent
with the greater di¡erence between strains at higher UV doses
that we observed in UV carcinogenesis and further supports a
role for UV immunosuppression.
The conclusions from our study are consistent with a UV car-
cinogenesis study in mice transgenic for CTLA-4Ig (Beissert et al,
1999). In these animals, costimulation via CTLA-4/B-7 in the T
cell immune response was inhibited and the T cell response was
skewed toward a Th1 response. These mice mounted an e¡ective
delayed-type hypersensitivity response to alloantigens but were
de¢cient in UV immunosuppression and also showed signi¢-
cantly decreased susceptibility to UV carcinogenesis, supporting
a signi¢cant role for UV immunosuppression in skin cancer out-
growth. Further, the proportion of poorly di¡erentiated (aggres-
sive) skin cancers was signi¢cantly reduced in these animals when
susceptibility to UV immunosuppression was diminished. Sup-
port for a role of immunosuppression in human skin cancer
comes from observations in transplant patients who receive im-
munosuppressive treatment. Such patients show greatly enhanced
susceptibility to sunlight-induced skin tumors and the tumors
that develop often show aggressive behavior (Euvrard et al, 1995;
DiGiovanna, 1998).
The possibility remains that the strain di¡erences we ob-
served here may have been due to parent of origin e¡ects
unrelated to UV immunosuppression, although any such e¡ects
would not be expected to show a UV dose^strain interaction, as
we have observed for UV immunosuppression. This question can
potentially be answered by investigating UV carcinogenesis in
strains of mice congenic for one or more of the autosomal loci
(Clemens et al, 2000) controlling susceptibility to the immuno-
suppressive e¡ects of UV radiation.
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